Navigation Links
Control by the matrix: RUB researchers decipher the role of proteins in the cell environment

How astrocytes, certain cells of the nervous system, are generated was largely unknown up to now. Bochum's researchers have now investigated what influence the cell environment, known as the extracellular matrix, has on this process. They found out that the matrix protein tenascin C has to be present in order for astrocytes to multiply and distribute in a controlled fashion in the spinal cord of mice. Together with colleagues from the RWTH Aachen, the scientists from RUB Department of Cell Morphology and Molecular Neurobiology report their findings in the journal Development.

Tenascin C regulates astrocyte development

Immature astrocytes produce tenascin C and secrete it into the extracellular matrix. From there, it controls the development of the cells. To characterise the role of the protein more precisely, the Bochum team lead by Prof. Dr. Andreas Faissner, Prof. Dr. Stefan Wiese and Dr. Michael Karus analysed astrocytes that were genetically manipulated so that they did not produce tenascin C. The scientists observed that the astrocytes without the protein divided for a longer period of time, and migrated later to their destination in the spinal cord. "As a consequence of the longer cell division phase, we found an increased number of mature astrocytes" explained Karus.

Gene activity altered

Also at the molecular level, the tenascin C manipulation leaves its mark. With colleagues at the RWTH Aachen, Bochum's researchers compared the gene activity in the spinal cord with and without tenascin C production. The absence of the protein not only affected genes that are typical of astrocytes. The scientists also documented expression level changes of genes that play a role for specific growth factors. These have an influence, for example, on the survival and division activity of different cell types.

Results also interesting for medical applications

Astrocytes take on a variety of tasks in the nervous system. They regulate the ion balance and the concentration of neurotransmitters, are part of the blood-brain barrier, and influence the activity of the nerve cells. In case of injuries to the central nervous system, or brain tumours, they form what are known as reactive astrocytes, which behave similarly to immature astrocytes. "So far, the function of tenascin C under such pathological conditions is largely unknown" said Karus. "However, if we find out more about the role of tenascin C during development, we will probably be able to better understand what affect it has, for example in spinal cord injuries."


Contact: Dr. Michael Karus
Ruhr-University Bochum

Related biology news :

1. Feasibility of using mycoherbicides to control illicit drug crops is uncertain
2. Controlled disorder -- scientists find way to form random molecular patterns
3. Biodegradable mulches successfully control weeds in container-grown arborvitae
4. Mid-ocean creatures control light to avoid becoming snacks
5. Scientists to use scent to control destructive rodent behavior
6. Impulsive versus controlled men: Disinhibited brains and disinhibited behavior
7. The future of airport passport control
8. New research from WALTHAM demonstrates the importance of portion control for maintaining healthy body weight in neutered female kittens
9. University of California Santa Barbara study reveals how gas, temperature controlled bacterial response to Deepwater Horizon spill
10. Scientists discover the proteins that control development of varicose veins
11. Control gene for developmental timing discovered
Post Your Comments:
(Date:4/19/2016)... -- The new GEZE SecuLogic access control ... system solution for all door components. It can be ... interface with integration authorization management system, and thus fulfills ... dimensions of the access control and the optimum integration ... considerable freedom of design with regard to the doors. ...
(Date:4/13/2016)... , April 13, 2016  IMPOWER physicians supporting Medicaid ... setting a new clinical standard in telehealth thanks to ... leveraging the higi platform, IMPOWER patients can routinely track ... and body mass index, and, when they opt in, ... convenient visit to a local retail location at no ...
(Date:3/23/2016)... Massachusetts , March 23, 2016 /PRNewswire/ ... im Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung ... Xura, Inc. (NASDAQ: MESG ), ... bekannt, dass das Unternehmen mit SpeechPro zusammenarbeitet, ... aus der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
(Date:6/23/2016)... WI (PRWEB) , ... June 23, 2016 , ... ... focused on quality, regulatory and technical consulting, provides a free webinar ... presented on July 13, 2016 at 12pm CT at no charge. , Incomplete ...
Breaking Biology Technology: